van Elmpt Wouter, McDermott Leah, Nijsten Sebastiaan, Wendling Markus, Lambin Philippe, Mijnheer Ben
Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, The Netherlands.
Radiother Oncol. 2008 Sep;88(3):289-309. doi: 10.1016/j.radonc.2008.07.008. Epub 2008 Aug 14.
Electronic portal imaging devices (EPIDs) have been the preferred tools for verification of patient positioning for radiotherapy in recent decades. Since EPID images contain dose information, many groups have investigated their use for radiotherapy dose measurement. With the introduction of the amorphous-silicon EPIDs, the interest in EPID dosimetry has been accelerated because of the favourable characteristics such as fast image acquisition, high resolution, digital format, and potential for in vivo measurements and 3D dose verification. As a result, the number of publications dealing with EPID dosimetry has increased considerably over the past approximately 15 years. The purpose of this paper was to review the information provided in these publications. Information available in the literature included dosimetric characteristics and calibration procedures of various types of EPIDs, strategies to use EPIDs for dose verification, clinical approaches to EPID dosimetry, ranging from point dose to full 3D dose distribution verification, and current clinical experience. Quality control of a linear accelerator, pre-treatment dose verification and in vivo dosimetry using EPIDs are now routinely used in a growing number of clinics. The use of EPIDs for dosimetry purposes has matured and is now a reliable and accurate dose verification method that can be used in a large number of situations. Methods to integrate 3D in vivo dosimetry and image-guided radiotherapy (IGRT) procedures, such as the use of kV or MV cone-beam CT, are under development. It has been shown that EPID dosimetry can play an integral role in the total chain of verification procedures that are implemented in a radiotherapy department. It provides a safety net for simple to advanced treatments, as well as a full account of the dose delivered. Despite these favourable characteristics and the vast range of publications on the subject, there is still a lack of commercially available solutions for EPID dosimetry. As strategies evolve and commercial products become available, EPID dosimetry has the potential to become an accurate and efficient means of large-scale patient-specific IMRT dose verification for any radiotherapy department.
近几十年来,电子射野影像装置(EPID)一直是放射治疗中患者体位验证的首选工具。由于EPID图像包含剂量信息,许多研究团队都对其用于放射治疗剂量测量进行了研究。随着非晶硅EPID的问世,因其具有图像采集速度快、分辨率高、数字格式以及可进行体内测量和三维剂量验证等优势特性,对EPID剂量学的研究兴趣迅速升温。因此,在过去约15年里,有关EPID剂量学的出版物数量大幅增加。本文旨在回顾这些出版物中提供的信息。文献中可得的信息包括各类EPID的剂量学特性和校准程序、使用EPID进行剂量验证的策略、EPID剂量学的临床应用方法(从点剂量验证到全三维剂量分布验证)以及当前的临床经验。目前,越来越多的诊所将直线加速器的质量控制、治疗前剂量验证以及使用EPID进行体内剂量测定作为常规操作。将EPID用于剂量学目的已渐趋成熟,如今已成为一种可靠且准确的剂量验证方法,可在众多情况下使用。将三维体内剂量测定与图像引导放射治疗(IGRT)程序(如使用千伏或兆伏锥形束CT)相结合的方法正在研发之中。研究表明,EPID剂量学在放射治疗科室实施的整个验证程序链中可发挥不可或缺的作用。它为从简单到复杂的治疗提供了安全保障,同时也能全面记录所给予的剂量。尽管具有这些优势特性且关于该主题的出版物众多,但EPID剂量学仍缺乏商业化的可用解决方案。随着策略的不断发展以及商业产品的问世,EPID剂量学有望成为任何放射治疗科室针对大规模个体化调强放疗剂量验证的准确且高效的手段。